Page 2 - Axio Biosolutions News Today

Leh  : The IIT Mandi mountain biking club, in partnership with Axio Biosolutions, blazed a trail through the magnificent landscapes of Leh in a remarkable display of endurance and discovery. In addition to embracing the spirit of adventure, this brea

INDUS X Summit and the startup-focussed defence exhibition coincided with Prime Minister Narendra Modi’s visit to the US

Bangalore  - In line with its sustainability vision, Axio Biosolutions, a leading medical technology company, has very efficiently and effectively implemented the principles of Design for Environment(DfE) across the value chain in the organization. T

The interactive kiosk will serve as an educational platform

BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in India and Asia.

[Report of 250 Pages] In 2022, the market for products for wound debridement is anticipated to be worth US$ 497.3 billion. The overall demand for wound debridement products is anticipated to increase at a CAGR of 5.6% between 2022 and 2032, reaching approximately US$ 857.55 Billion by 2032 due to the rise in the inc...

The National Medical Devices Policy 2023 announcement by the Centre has delighted city-based biomedical device...

Chronic wound care management is more than just dressing change or bandaging. Let’s look at some of the latest developments in wound care management. TheHealthSite.com

Get Injuries latest news, Article video and Photos on Injuries Explore latest health updates, news, information from TheHealthSite.com

Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance. TheHealthSite.com